Table 9.6e

Immunosuppression Use for Maintenance

Prior to Discharge, 1995 to 2004

Recipients with Liver Transplants

  Year of Transplant
1995 1996 1997 1998 1999 2000 2001 2002 2003 2004
Functioning Graft at Discharge 3,344 3,435 3,578 3,929 4,090 4,314 4,563 4,773 5,116 5,616
With Immunosuppression Info 3,313 3,323 3,426 3,743 3,936 4,298 4,558 4,769 5,110 5,540
Corticosteroids Any in Category 88.2% 91.7% 94.9% 94.5% 93.0% 91.9% 90.2% 90.3% 82.4% 80.5%
Steroids 88.2% 91.7% 94.9% 94.5% 93.0% 91.9% 90.2% 90.3% 82.4% 80.5%
Cyclosporine Any in Category 47.1% 40.8% 38.3% 31.1% 25.9% 18.5% 11.9% 10.2% 8.7% 8.0%
Cyclosporin 39.7% 4.9% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Sandimmmune 2.8% 6.7% 4.3% 4.0% 3.8% 3.1% 1.3% 1.1% 0.4% 0.5%
Neoral 4.6% 29.2% 34.0% 27.0% 22.1% 15.3% 9.6% 7.4% 7.4% 6.5%
Gengraf 0.0% 0.0% 0.0% 0.0% 0.0% 0.1% 0.6% 1.5% 0.8% 0.8%
Eon 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.4% 0.2% 0.1% 0.2%
Tacrolimus Any in Category 47.5% 55.5% 59.0% 67.1% 71.6% 76.5% 83.2% 86.8% 88.8% 88.8%
Tacrolimus 47.5% 55.5% 59.0% 67.1% 71.6% 76.5% 83.2% 86.8% 88.8% 88.8%
Antimetabolites Any in Category 42.0% 48.5% 43.4% 42.1% 44.5% 48.3% 50.7% 51.6% 57.4% 58.2%
Mycophenolate Mofetil 5.9% 22.4% 24.2% 30.2% 36.7% 43.2% 47.6% 48.0% 54.2% 55.7%
Mycophenolate Sodium 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.4%
Azathioprine 35.9% 26.1% 19.0% 11.6% 7.6% 5.0% 3.0% 3.5% 3.2% 2.1%
Leflunomide 0.0% 0.0% 0.0% 0.1% 0.1% 0.0% 0.0% 0.0% 0.0% 0.0%
Cytoxan 0.2% 0.1% 0.2% 0.2% 0.1% 0.0% 0.1% 0.1% 0.0% 0.0%
mTOR Inhibitors Any in Category 0.0% 0.1% 0.0% 0.8% 0.6% 9.4% 9.9% 6.6% 4.4% 5.0%
Sirolimus 0.0% 0.1% 0.0% 0.8% 0.5% 9.4% 9.9% 6.6% 4.3% 5.0%
Everolimus 0.0% 0.0% 0.0% 0.0% 0.2% 0.0% 0.0% 0.0% 0.0% 0.0%


Source: OPTN/SRTR Data as of May 2, 2005.

Individual drug percentages will not necessarily add up to the drug category percentages, as patients maybe prescribed more than one drug within the same category.